Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions

Table 2

Reevaluation of antirheumatic effects of tocilizumab in actual medical practice. Summary of the contents of the three actual medical practice of tocilizumab for rheumatoid arthritis.

Study	Country	Patient number	Registry	Evaluation
TAMARA	Germany	286	Sep. 2008~Sep. 2009	Disease activity
				EULAR response
				ACR response
				Adverse events
				2011 ACR/EULAR remission
DAMBIO	Denmark	178	~April 2010	Disease activity
				EULAR response
				Drug survival
REACTION	Japan	229	April 2008~March 2009	Disease activity
				EULAR response
				Adverse events
				Drug survival